Biovie (BIVI) Short-Term Debt issuances (2017 - 2018)
Biovie (BIVI) posted Short-Term Debt issuances of $14000.0 for Q3 2018, down 44.0% sequentially from $25000.0 in Q3 2017, and down 44.0% YoY from $25000.0 in Q3 2017.
Biovie (BIVI) Short-Term Debt issuances (2017 - 2018) Analysis & Trends
Biovie has reported Short-Term Debt issuances for 2 years, with the latest figure at $14000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 14,000.00 |
| Sep 30, 2018 | 14,000.00 |
| Sep 30, 2017 | 25,000.00 |
| Sep 30, 2017 | 25,000.00 |